CD274 and neoplasm: [47] developed a positively charged, amphiphilic anti-PD-L1 peptide nanomedicine with strong cellular and tissue permeability, capable of generating ROS and inducing ICD under laser conditions while modulating the tumor’s microenvironment, leading to antitumor immunotherapy.